PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
37.12%
Net income growth under 50% of MCHP's 190.98%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.26%
Negative yoy D&A while MCHP is 4.09%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
120.83%
Some yoy growth while MCHP is negative at -80.18%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
17.19%
SBC growth well above MCHP's 1.70%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-153.88%
Negative yoy working capital usage while MCHP is 135.03%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-129.40%
AR is negative yoy while MCHP is 85.99%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-37.36%
Both reduce yoy inventory, with MCHP at -70.10%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-209.91%
Both negative yoy AP, with MCHP at -84.11%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-292.59%
Negative yoy usage while MCHP is 242.77%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
99.15%
Well above MCHP's 0.03%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-66.82%
Negative yoy CFO while MCHP is 25.87%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
12.50%
Some CapEx rise while MCHP is negative at -172.02%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
18.91%
Less growth in investment purchases vs. MCHP's 85.29%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
9.86%
We have some liquidation growth while MCHP is negative at -26.71%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
111.64%
Lower net investing outflow yoy vs. MCHP's 448.45%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
241.35%
We slightly raise equity while MCHP is negative at -70.90%. John Neff sees competitor possibly preserving share count or buying back shares.
-13.17%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.